European organisations react to a recent update in the pharmaceutical industry’s Code of Practice. A group of European organisations active in the field of transparency issued a joint statement to highlight the shortcomings in the new European Federation of Pharmaceutical Industries and Associations (EFPIA) Code of Practice. The response raises concerns about the privileges granted […]

CPME response to public consultation on how the EMA engages with medicine developers before they apply for authorisations to market their medicines in the EU 

On 11 June 2015, the CPME Executive Committee adopted the ’CPME response to the EMA Good practice guides on medication errors’ (CPME 2015/062 FINAL)

On 23 November 2013, the CPME Board endorsed the WMA Declaration of Helsinki on ethical principles for medical research involving human subjects, as adopted by the WMA General Assembly in Fortaleza – Brazil, October 2013.

On 17 September 2013, the CPME Executive Committee adopted the “ CPME Response to the EMA public consultation on the “Publication and access to clinical-trial data” Policy” (CPME 2013/088 FINAL)

On 13 June 2013, the CPME Executive Committee adopted the “CPME Response to the WMA public consultation on the draft revised text of the Declaration of Helsinki”